242 related articles for article (PubMed ID: 11796590)
1. Human Stx2-specific monoclonal antibodies prevent systemic complications of Escherichia coli O157:H7 infection.
Mukherjee J; Chios K; Fishwild D; Hudson D; O'Donnell S; Rich SM; Donohue-Rolfe A; Tzipori S
Infect Immun; 2002 Feb; 70(2):612-9. PubMed ID: 11796590
[TBL] [Abstract][Full Text] [Related]
2. Immunization of pregnant cows with Shiga toxin-2 induces high levels of specific colostral antibodies and lactoferrin able to neutralize E. coli O157:H7 pathogenicity.
Albanese A; Sacerdoti F; Seyahian EA; Amaral MM; Fiorentino G; Fernandez Brando R; Vilte DA; Mercado EC; Palermo MS; Cataldi A; Zotta E; Ibarra C
Vaccine; 2018 Mar; 36(13):1728-1735. PubMed ID: 29483033
[TBL] [Abstract][Full Text] [Related]
3. Shiga toxin-producing Escherichia coli infection and antibodies against Stx2 and Stx1 in household contacts of children with enteropathic hemolytic-uremic syndrome.
Ludwig K; Sarkim V; Bitzan M; Karmali MA; Bobrowski C; Ruder H; Laufs R; Sobottka I; Petric M; Karch H; Müller-Wiefel DE
J Clin Microbiol; 2002 May; 40(5):1773-82. PubMed ID: 11980959
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Urtoxazumab (TMA-15 Humanized Monoclonal Antibody Specific for Shiga Toxin 2) Against Post-Diarrheal Neurological Sequelae Caused by Escherichia coli O157:H7 Infection in the Neonatal Gnotobiotic Piglet Model.
Moxley RA; Francis DH; Tamura M; Marx DB; Santiago-Mateo K; Zhao M
Toxins (Basel); 2017 Jan; 9(2):. PubMed ID: 28134751
[TBL] [Abstract][Full Text] [Related]
5. Human antibody against shiga toxin 2 administered to piglets after the onset of diarrhea due to Escherichia coli O157:H7 prevents fatal systemic complications.
Sheoran AS; Chapman-Bonofiglio S; Harvey BR; Mukherjee J; Georgiou G; Donohue-Rolfe A; Tzipori S
Infect Immun; 2005 Aug; 73(8):4607-13. PubMed ID: 16040972
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus vector expressing Stx1/Stx2-neutralizing agent protects piglets infected with Escherichia coli O157:H7 against fatal systemic intoxication.
Sheoran AS; Dmitriev IP; Kashentseva EA; Cohen O; Mukherjee J; Debatis M; Shearer J; Tremblay JM; Beamer G; Curiel DT; Shoemaker CB; Tzipori S
Infect Immun; 2015 Jan; 83(1):286-91. PubMed ID: 25368111
[TBL] [Abstract][Full Text] [Related]
7. Antibody-based protection of gnotobiotic piglets infected with Escherichia coli O157:H7 against systemic complications associated with Shiga toxin 2.
Donohue-Rolfe A; Kondova I; Mukherjee J; Chios K; Hutto D; Tzipori S
Infect Immun; 1999 Jul; 67(7):3645-8. PubMed ID: 10377152
[TBL] [Abstract][Full Text] [Related]
8. Intracellular neutralization of shiga toxin 2 by an a subunit-specific human monoclonal antibody.
Krautz-Peterson G; Chapman-Bonofiglio S; Boisvert K; Feng H; Herman IM; Tzipori S; Sheoran AS
Infect Immun; 2008 May; 76(5):1931-9. PubMed ID: 18285498
[TBL] [Abstract][Full Text] [Related]
9. Biodistribution and elimination kinetics of systemic Stx2 by the Stx2A and Stx2B subunit-specific human monoclonal antibodies in mice.
Sheoran A; Jeong KI; Mukherjee J; Wiffin A; Singh P; Tzipori S
BMC Immunol; 2012 Jun; 13():27. PubMed ID: 22655967
[TBL] [Abstract][Full Text] [Related]
10. Stx2-specific human monoclonal antibodies protect mice against lethal infection with Escherichia coli expressing Stx2 variants.
Sheoran AS; Chapman S; Singh P; Donohue-Rolfe A; Tzipori S
Infect Immun; 2003 Jun; 71(6):3125-30. PubMed ID: 12761090
[TBL] [Abstract][Full Text] [Related]
11. Neutralizing antibodies to Shiga toxin type 2 (Stx2) reduce colonization of mice by Stx2-expressing Escherichia coli O157:H7.
Mohawk KL; Melton-Celsa AR; Robinson CM; O'Brien AD
Vaccine; 2010 Jul; 28(30):4777-85. PubMed ID: 20472033
[TBL] [Abstract][Full Text] [Related]
12. Engineering an anti-Stx2 antibody to control severe infections of EHEC O157:H7.
Ma Y; Mao X; Li J; Li H; Feng Y; Chen H; Luo P; Gu J; Yu S; Zeng H; Guo G; Yang K; Zou Q
Immunol Lett; 2008 Dec; 121(2):110-5. PubMed ID: 19007817
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of a recombinant Intimin, EspB and Shiga toxin 2B vaccine in calves experimentally challenged with Escherichia coli O157:H7.
Martorelli L; Garimano N; Fiorentino GA; Vilte DA; Garbaccio SG; Barth SA; Menge C; Ibarra C; Palermo MS; Cataldi A
Vaccine; 2018 Jun; 36(27):3949-3959. PubMed ID: 29807709
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a human monoclonal antibody against Shiga toxin 2 expressed in Chinese hamster ovary cells.
Akiyoshi DE; Rich CM; O'Sullivan-Murphy S; Richard L; Dilo J; Donohue-Rolfe A; Sheoran AS; Chapman-Bonofiglio S; Tzipori S
Infect Immun; 2005 Jul; 73(7):4054-61. PubMed ID: 15972493
[TBL] [Abstract][Full Text] [Related]
15. Vaccination of pregnant cows with EspA, EspB, γ-intimin, and Shiga toxin 2 proteins from Escherichia coli O157:H7 induces high levels of specific colostral antibodies that are transferred to newborn calves.
Rabinovitz BC; Gerhardt E; Tironi Farinati C; Abdala A; Galarza R; Vilte DA; Ibarra C; Cataldi A; Mercado EC
J Dairy Sci; 2012 Jun; 95(6):3318-26. PubMed ID: 22612965
[TBL] [Abstract][Full Text] [Related]
16. Escherichia coli O157:H7 strains that express Shiga toxin (Stx) 2 alone are more neurotropic for gnotobiotic piglets than are isotypes producing only Stx1 or both Stx1 and Stx2.
Donohue-Rolfe A; Kondova I; Oswald S; Hutto D; Tzipori S
J Infect Dis; 2000 May; 181(5):1825-9. PubMed ID: 10823794
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo protective efficacies of antibodies that neutralize the RNA N-glycosidase activity of Shiga toxin 2.
Jeong KI; Chapman-Bonofiglio S; Singh P; Lee J; Tzipori S; Sheoran AS
BMC Immunol; 2010 Mar; 11():16. PubMed ID: 20334660
[TBL] [Abstract][Full Text] [Related]
18. Production and characterization of protective human antibodies against Shiga toxin 1.
Mukherjee J; Chios K; Fishwild D; Hudson D; O'Donnell S; Rich SM; Donohue-Rolfe A; Tzipori S
Infect Immun; 2002 Oct; 70(10):5896-9. PubMed ID: 12228326
[TBL] [Abstract][Full Text] [Related]
19. Shiga toxin 2-specific but not shiga toxin 1-specific human monoclonal antibody protects piglets challenged with enterohemorrhagic Escherichia coli producing shiga toxin 1 and shiga toxin 2.
Jeong KI; Tzipori S; Sheoran AS
J Infect Dis; 2010 Apr; 201(7):1081-3. PubMed ID: 20196656
[TBL] [Abstract][Full Text] [Related]
20. Neutralizing activity of bovine colostral antibody against verotoxin derived from enterohemorrhagic Escherichia coli O157:H7 in mice.
Kuribayashi T; Seita T; Fukuyama M; Furuhata K; Honda M; Matsumoto M; Seguchi H; Yamamoto S
J Infect Chemother; 2006 Oct; 12(5):251-6. PubMed ID: 17109087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
